News of Note—GlaxoSmithKline in Nigeria; Mexico fights shortages

Financial market data. Image: Pixabay
(Pixabay)

> GlaxoSmithKline Consumer Nigeria has selected Nigeria's Fidson Healthcare to manufacture five formations of its respiratory and wellness products for the Nigerian market. Story

> Lupin has received a notice from the FDA that an inspection of its plant in Goa resulted in a finding of Official Action Indicated. Story

> The Mexican government has pledged to fix drug shortages at hospitals that have been blamed on a government plan aimed at cutting costs. Story

> The FDA's Office of Pharmaceutical Quality has issued a report on strides made to improve the global drug supply that comes into the U.S. Report (PDF)

> Fujifilm Diosynth Biotechnologies is investing £3.6 million to build a new facility at its site in the U.K., the first phase of a £12.6 million expansion project. Story

> According to a new report from CPhI, the Middle East currently imports about 90% of its medicines and is ripe for expansion for local manufacturing. Report

Suggested Articles

AbbVie will soon own Allergan’s prized Botox franchise, and along with its roughly $4 billion in sales, it will get a new $176 million plant.

Merck KGaA has big plans for a site in Switzerland where it intends to knit together biologics development and manufacturing. 

The FDA has found some issues with Biocon’s small molecule plant in Bengaluru, India.